Status:
UNKNOWN
Validation and Interobserver Reliability of a Simple Ultrasound Score for Crohn's Disease
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Alesund Hospital
University Hospital of North Norway
Conditions:
Crohn Disease
Ultrasound
Eligibility:
All Genders
18-75 years
Brief Summary
Crohn's disease (CD) is a chronic inflammatory disease in the gastrointestinal (GI) tract. It is characterized by an alternating course between remission and relapse, which necessitates subsequent adj...
Detailed Description
Although there are some studies where they used conventional ultrasound and contrast enhanced ultrasound (CEUS) on CD patients to construct ultrasonographic scoring systems, there is currently no vali...
Eligibility Criteria
Inclusion
- Patient with Crohn's Disease scheduled for ileocolonoscopy.
Exclusion
- \<18 years
- \>75 years
- CD located in other areas than the terminal ileum or colon
- pregnancy
- chronic obstructive lung disease
- acute coronary heart disease
- clinically unstable heart disease
- ongoing gastroenteritis
- presence of an intra-abdominal abscess or a fistula
- obesity (BMI\>30 kg/m2)
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT03481751
Start Date
January 8 2018
End Date
December 20 2022
Last Update
October 4 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Haukeland University Hospital
Bergen, Hordaland, Norway, 5021
2
Ålesund Hospital
Ålesund, Møre og Romsdal, Norway
3
University Hospital of North Norway Tromsø
Tromsø, Troms, Norway